Stephen Morlock, Director at BioPharmX Corp (BPMX), bought 12,000 shares at $1.53 ($18K) on 2016-01-14, disclosed to the SEC on 2016-01-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.52 | 6,500 | $10K | 54.0% |
| 2 | $1.53 | 5,500 | $8K | 46.0% |
| Total | $1.52 avg | 12,000 | $18K | 100% |
| Filing → |
| BPMX | BUY | 2016-11-29 | $150K | — | Filing → |
| BPMX | BUY | 2016-01-12 | $9K | — | Filing → |
| BPMX | BUY | 2016-01-11 | $7K | — | Filing → |